Mayo Clinic
Michael D. Jensen
Adults who gain most of their excess weight in the abdominal area typically do not respond to insulin in the same way as lean adults. Researchers are trying to understand why fat tissue responds differently in people with different body types.
Obesity
Insulin
Early Phase 1
Measure regional FFA release in volunteers with and without UBO under two different conditions that suppress lipolysis and a condition that markedly stimulates lipolysis.
Study Type : | Interventional |
Estimated Enrollment : | 48 participants |
Masking : | None (Open Label) |
Primary Purpose : | Basic Science |
Official Title : | Insulin Regulation of Regional Lipolysis |
Actual Study Start Date : | June 1, 2024 |
Estimated Primary Completion Date : | June 1, 2028 |
Estimated Study Completion Date : | July 1, 2028 |
Arm | Intervention/treatment |
---|---|
Other: obesity status obesity |
Drug: Insulin |
Other: lean non-obese |
Drug: Insulin |
Ages Eligible for Study: | 18 Years to 65 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905